IPS Research has conducted over 600 Phase I-IV trials in a wide range of indications, including all of those listed below.
- ADHD (all ages)
- Allergy
- Alzheimer’s disease
- Anxiety Disorders (all ages) – GAD, Panic, PTSD, OCD, Trichotillomania
- Asthma (all ages)
- Binge Eating Disorder
- Bipolar Disorder (Including all ages and subtypes)
- Cardiovascular Disorders
- COPD
- Conjunctivitis
- Chronic Pain
- Depressive disorders (all ages)
- Diabetes
- Diabetic Neuropathy
- Erectile Dysfunction
- Fibromyalgia
- Gastrointestinal disorders
- Insomnia (all ages)
- Major Depression (Including all ages and subtypes)
- Migraine
- Narcolepsy
- Ophthalmologic disorders
- Opioid-Induced Constipation
- Pain management
- Schizophrenia/Schizoaffective Disorder
- Sleep Medicine
- Vaccines
- Women’s Health
